LumiraDx Limited (NASDAQ:LMDX) Q2 2022 Earnings Conference Call August 18, 2022 8:00 AM ET

Company Participants

Colleen McMillen - Vice President, Communications

Ron Zwanziger - Chairman and CEO

Dorian LeBlanc - Chief Financial Officer

Pooja Pathak - Chief Product Officer

Conference Call Participants

Vijay Kumar - Evercore ISI

Jeffrey Cohen - Ladenburg

Mark Massaro - BTIG

Operator

Good day. And welcome to the LumiraDx Second Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. As a reminder, this call may be recorded.

I would now like to turn the call over to Colleen McMillen, VP, Communications. You may begin.

Colleen McMillen

Hello, everyone. We would like to welcome you to today’s call to discuss LumiraDx’s second quarter 2022 financial results issued earlier today. With us are LumiraDx’s Chairman and CEO, Ron Zwanziger; Chief Financial Officer, Dorian Leblanc; and Chief Product Officer, Pooja Pathak. The press release announcing our financial results is posted on the Investor Relations section of the company’s website at lumiradx.com.

Before we begin, I would like to caution listeners that any statements we make today, other than historical facts are forward-looking statements made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.

Please be aware that all such forward-looking statements involve risks and uncertainties, such as those detailed in our annual report on Form 20-F for the year ended December 31, 2021, which was filed with the SEC on April 13, 2022, and other filings that we make with the SEC. Any forward-looking statements that we make must be considered in light of these factors. Actual results may vary materially.

Also during the course of today’s call, we may refer to certain non-IFRS financial measures. Non-IFRS financial measures should not be considered in isolation from or as a substitute for financial information presented in compliance with IFRS. There is a reconciliation schedule showing the IFRS versus non-IFRS results currently available in our press release issued earlier today, which can be found on our website.

I will now turn the call over to Ron Zwanziger for opening remarks. We will then provide financial and business updates before answering questions. Ron?

Ron Zwanziger

Thanks, Colleen. We continue to deliver on our mission and promise to transform community-based care. Looking ahead, as part of the transformation, the company has four key priorities for the next 12 months to 18 months and I’d like to provide updates on each of these areas.